Today we thought we would update you on one of our other collaborative research agreements, Globiotics. This represents about 5% of the teams total efforts and the primary focus is on addressing regulatory challenges rather than technical challenges (in contrast to our plants which are the other way round: clear regulatory pathway but challenging technical issues).